Bifunctional Opioid/Melanocortin Peptidomimetics for Use in Neuropathic Pain: Variation in the Type and Length of the Linker Connecting the Two Pharmacophores
Authors:
- Ewa WitkowskaEWEwa Witkowska
- Magda GodlewskaMGMagda Godlewska
- Jowita OsiejukJOJowita Osiejuk
- Sandra GątarzSGSandra Gątarz
- Beata WileńskaBWBeata Wileńska
- Katarzyna KosińskaKKKatarzyna Kosińska
- Joanna Starnowska-SokółJSJoanna Starnowska-Sokół
- Anna PiotrowskaAPAnna Piotrowska
- Piotr F. J. LipińskiPLPiotr F. J. Lipiński
- Joanna MatalińskaJMJoanna Matalińska
- Jolanta DyniewiczJDJolanta Dyniewicz
- Paweł K. HalikPHPaweł K. Halik
Open Access
- 8 January 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (2) , 674
Abstract
Based on the mechanism of neuropathic pain induction, a new type of bifunctional hybrid peptidomimetics was obtained for potential use in this type of pain. Hybrids consist of two types of pharmacophores that are connected by different types of linkers. The first pharmacophore is an opioid agonist, and the second pharmacophore is an antagonist of the pronociceptive system, i.e., an antagonist of the melanocortin-4 receptor. The results of tests in acute and neuropathic pain models of the obtained compounds have shown that the type of linker used to connect pharmacophores had an effect on antinociceptive activity. Peptidomimetics containing longer flexible linkers were very effective at low doses in the neuropathic pain model. To elucidate the effect of linker lengths, two hybrids showing very high activity and two hybrids with lower activity were further tested for affinity for opioid (mu, delta) and melanocortin-4 receptors. Their complexes with the target receptors were also studied by molecular modelling. Our results do not show a simple relationship between linker length and affinity for particular receptor types but suggest that activity in neuropathic pain is related to a proper balance of receptor affinity rather than maximum binding to any or all of the target receptors.Keywords
Funding Information
- Narodowe Centrum Nauki (MAESTRO 2012/06/A/NZ4/00028, OPUS 2018/29/B/NZ7/00082)
This publication has 44 references indexed in Scilit:
- Novel peptide ligands with dual acting pharmacophores designed for the pathophysiology of neuropathic painBrain Research, 2011
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Development of Novel Enkephalin Analogues that Have Enhanced Opioid Activities at Both μ and δ Opioid ReceptorsJournal of Medicinal Chemistry, 2007
- Inhibition of morphine tolerance by spinal melanocortin receptor blockadePain, 2005
- Modulation of melanocortin-induced changes in spinal nociception by μ-opioid receptor agonist and antagonist in neuropathic ratsNeuroReport, 2002
- Characterisation of melanocortin receptor subtypes by radioligand binding analysisEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- An Index of Molecular Flexibility from Kappa Shape AttributesQuantitative Structure-Activity Relationships, 1989
- Potent analgesic activity of the enkephalin-like tetrapeptide H-Tyr-D-Ala-Gly-Phe-NH2Life Sciences, 1978
- A novel cyclic undecapeptide, Wy-40,770, with prolonged growth hormone release inhibiting activityBiochemical and Biophysical Research Communications, 1976
- Use of Anhydrous Hydrogen Fluoride in Peptide Synthesis. I. Behavior of Various Protective Groups in Anhydrous Hydrogen FluorideBulletin of the Chemical Society of Japan, 1967